10X GENOMICS INC-CLASS A (TXG:NASDAQ)
$46.82 0.9 (1.9599%)
Analysed 10X GENOMICS INC-CLASS A (TXG:NASDAQ) News Sources
Is 10x Genomics (TXG) Overvalued Following Its Earnings Beat?
09-07-2026
yahoo.com
Does 10x Genomics (TXG) Leaving Russell Value Indexes Reframe Its Growth Versus Profitability Story?
10-07-2026
yahoo.com
Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group
13-07-2026
yahoo.com
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?
14-07-2026
fool.com
Cathie Wood’s ARK Invest Doubles Down On Circle In Two Funds At Once, Trims Robinhood Again
15-07-2026
stocktwits.com
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
15-07-2026
yahoo.com
3 Russell 2000 Stocks We Steer Clear Of
16-07-2026
yahoo.com
1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges
20-07-2026
yahoo.com
Cathie Wood Dumps $39 Million Worth of AMD Stock
20-07-2026
yahoo.com
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
24-07-2026
yahoo.com
What is the current price of 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The current price of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is $46.82.
10X GENOMICS INC-CLASS A (TXG:NASDAQ) absolute price change since previous trading day?
The absolute price change of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) since the previous trading day is $0.9.
10X GENOMICS INC-CLASS A (TXG:NASDAQ) percentage price change since previous trading day?
The percentage price change of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) since the previous trading day is 1.9599%.
What is the most recent average sentiment score for 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The most recent average sentiment score for 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The most recent sentiment for 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is .
SEC-8K** Filing Available For 10X GENOMICS INC-CLASS A (TXG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.